---
$id: https://graph.org.ai/products/commodity/51191552
$type: Product
source: UNSPSC
code: "51191552"
title: "Hydroxindasate"
class: "51191500"
classTitle: "Diuretics"
family: "51190000"
familyTitle: "Agents affecting water and electrolytes"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Hydroxindasate

**UNSPSC Code**: 51191552
**Class**: [Diuretics](Diuretics.mdx)
**Family**: [Agents affecting water and electrolytes](../Agents affecting water and electrolytes.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a diuretic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U8687J667P. European Medicines Agency schedules Hydroxindasate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08072MIG. Hydroxindasate generally arises in the molecular formula C21H24N2O3. The term HYDROXINDASATE is an International Non-Proprietary Name or INN. HYDROXINDASATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule hydroxindasate under HS 29339990 and SITC 51577. As of Q4 2014, HYDROXINDASATE remains the US FDA Preferred Term for this commodity. Hydroxindasate bears US NLM identifiers UMLS ID C1881075 and NCI Concept Code C65866. SMILES: O(C1CC2C(C(N(C2CC1)CC1CCC(OC)CC1)C)CCN)C(=O)C.

